Table 3.
AUC [CI 95%] | Cut-off | Sensitivity | Specificity | PPV | NPV | |
---|---|---|---|---|---|---|
CD61+PKCe+/ CD61+ |
0.756 [0.606–0.907] |
0.913 | 50% | 98.7% | 85.7% | 92.6% |
CD3−CD61+PKCe+/ CD3−CD61+ |
0.875 [0.774–0.976] |
0.802 | 87.5% | 84.4% | 50% | 97.7% |
AUC [CI 95%] | Cut-off | Sensitivity | Specificity | PPV | NPV | |
---|---|---|---|---|---|---|
CD61+PKCe+/ CD61+ |
0.756 [0.606–0.907] |
0.913 | 50% | 98.7% | 85.7% | 92.6% |
CD3−CD61+PKCe+/ CD3−CD61+ |
0.875 [0.774–0.976] |
0.802 | 87.5% | 84.4% | 50% | 97.7% |